Aberrant upregulation of 14-3-3σ and EZH2 expression serves as an inferior prognostic biomarker for hepatocellular carcinoma
about
Involvement of 14-3-3 Proteins in Regulating Tumor Progression of Hepatocellular CarcinomaPrognostic value of high EZH2 expression in patients with different types of cancer: a systematic review with meta-analysisMicroRNA-31 functions as a tumor suppressor by regulating cell cycle and epithelial-mesenchymal transition regulatory proteins in liver cancer.Identification of 14-3-3 Proteins Phosphopeptide-Binding Specificity Using an Affinity-Based Computational Approach.MicroRNA-506 suppresses tumor proliferation and metastasis in colon cancer by directly targeting the oncogene EZH2Regulation of aldo-keto-reductase family 1 B10 by 14-3-3ε and their prognostic impact of hepatocellular carcinoma.Global proteomic profiling in multistep hepatocarcinogenesis and identification of PARP1 as a novel molecular marker in hepatocellular carcinoma.Coexistence of YWHAZ amplification predicts better prognosis in muscle-invasive bladder cancer with CDKN2A or TP53 loss.Paracrine regulation of matrix metalloproteinases contributes to cancer cell invasion by hepatocellular carcinoma-secreted 14-3-3σ.Regulation and role of post-translational modifications of enhancer of zeste homologue 2 in cancer developmentBinding of 14-3-3 reader proteins to phosphorylated DNMT1 facilitates aberrant DNA methylation and gene expression.14-3-3σ downregulation suppresses ICC metastasis via impairing migration, invasion, and anoikis resistance of ICC cells.Identification of a novel YAP-14-3-3ζ negative feedback loop in gastric cancer.14-3-3σ Protein Expression in Canine Renal Cell Carcinomas.microRNA-874 suppresses tumor proliferation and metastasis in hepatocellular carcinoma by targeting the DOR/EGFR/ERK pathway.Knockdown of tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta (YWHAZ) enhances tumorigenesis both in vivo and in vitro in bladder cancer.
P2860
Q27001182-F39A441E-20F6-4EE7-873F-6AFB81BCCC6EQ27853296-01C405E1-37A2-48B8-B1FE-C3B08E0464A2Q35781512-7B30C5DB-8F22-4D50-91B9-D4143CF9CDCDQ35909432-88B24B99-440A-46E1-BB77-2302C8FD777EQ36544911-D9F1C723-269D-4138-835C-A0E48C6F5F43Q36629475-DF4C0601-C05E-47A0-884E-CD27C7CD7833Q37046449-83AA9821-C69D-47F9-A62F-948A1EC55C77Q37376373-718CC203-FECA-4181-8AA5-5DCE0C7B60DBQ37392890-1AA776AA-AC46-4E10-A5BC-419E7614E1DDQ37545071-1C6E5659-7381-483A-AA0F-AF961AE7FD85Q38667577-F058B8B0-61DC-4DE4-A890-CA21F960C80EQ40221658-D764FBED-0B0F-44BC-993E-778C8D32AC8DQ42700861-D97165A1-6C4B-42D5-B029-4A36D52E725CQ47395177-49CFB455-CBD4-4554-A472-49FD53B89A70Q49646793-3DD158D6-A36B-49C5-8960-C0DE365DAF37Q52728272-B98E46BC-F846-4563-B85F-D7EA05CF94B1
P2860
Aberrant upregulation of 14-3-3σ and EZH2 expression serves as an inferior prognostic biomarker for hepatocellular carcinoma
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Aberrant upregulation of 14-3- ...... r for hepatocellular carcinoma
@ast
Aberrant upregulation of 14-3- ...... r for hepatocellular carcinoma
@en
Aberrant upregulation of 14-3- ...... r for hepatocellular carcinoma
@nl
type
label
Aberrant upregulation of 14-3- ...... r for hepatocellular carcinoma
@ast
Aberrant upregulation of 14-3- ...... r for hepatocellular carcinoma
@en
Aberrant upregulation of 14-3- ...... r for hepatocellular carcinoma
@nl
prefLabel
Aberrant upregulation of 14-3- ...... r for hepatocellular carcinoma
@ast
Aberrant upregulation of 14-3- ...... r for hepatocellular carcinoma
@en
Aberrant upregulation of 14-3- ...... r for hepatocellular carcinoma
@nl
P2093
P2860
P3181
P1433
P1476
Aberrant upregulation of 14-3- ...... r for hepatocellular carcinoma
@en
P2093
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0107251
P407
P50
P577
2014-01-01T00:00:00Z